Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Hoth Therapeutics stock

Learn how to easily invest in Hoth Therapeutics stock.

Hoth Therapeutics Inc is a biotechnology business based in the US. Hoth Therapeutics shares (HOTH) are listed on the NASDAQ and all prices are listed in US Dollars. Hoth Therapeutics employs 4 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Hoth Therapeutics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – HOTH – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Hoth Therapeutics stock price (NASDAQ: HOTH)

Use our graph to track the performance of HOTH stocks over time.

Hoth Therapeutics shares at a glance

Information last updated 2022-10-02.
Latest market close$0.34
52-week range$0.34 - $1.75
50-day moving average $0.42
200-day moving average $0.54
Wall St. target price$3.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.53

Buy Hoth Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Hoth Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Hoth Therapeutics price performance over time

Historical closes compared with the close of $0.34 from 2022-10-05

1 week (2022-09-29) -6.87%
1 month (2022-09-06) -17.27%
3 months (2022-07-06) -18.07%
6 months (2022-04-05) -50.28%
1 year (2021-10-06) -70.69%
2 years (2020-10-06) -82.20%
3 years (2019-10-04) 4.5062
5 years (2017-10-02) N/A

Hoth Therapeutics financials

Gross profit TTM $0
Return on assets TTM -47.86%
Return on equity TTM -86.52%
Profit margin 0%
Book value $0.35
Market capitalisation $11.2 million

TTM: trailing 12 months

Hoth Therapeutics share dividends

We're not expecting Hoth Therapeutics to pay a dividend over the next 12 months.

Hoth Therapeutics share price volatility

Over the last 12 months, Hoth Therapeutics's shares have ranged in value from as little as $0.341 up to $1.75. A popular way to gauge a stock's volatility is its "beta".

HOTH.US volatility(beta: 0.91)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Hoth Therapeutics's is 0.9122. This would suggest that Hoth Therapeutics's shares are less volatile than average (for this exchange).

Hoth Therapeutics overview

Hoth Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-ALZ for the treatment and/or prevention of Alzheimer's or other neuroinflammatory diseases; HT-003 to treat inflammatory bowel diseases, as well as acne and psoriasis; HT-004 for treatment of asthma and allergies using inhalational administration; HT-006 to treat lung diseases resulting from bacterial infections; and HT-002, a novel peptide for treating COVID-19. The company is also developing BioLexa Platform, a proprietary, patented, drug compound platform which is in phase I clinical trial for the treatment of eczema; and HT-005 for treating patients with lupus. The company has license agreements with the George Washington University; the University of Maryland; Isoprene Pharmaceuticals, Inc. ; the North Carolina State University; Chelexa BioSciences, Inc. ; Zylö Therapeutics, Inc.

Frequently asked questions

What percentage of Hoth Therapeutics is owned by insiders or institutions?
Currently 2.751% of Hoth Therapeutics shares are held by insiders and 8.239% by institutions.
How many people work for Hoth Therapeutics?
Latest data suggests 4 work at Hoth Therapeutics.
When does the fiscal year end for Hoth Therapeutics?
Hoth Therapeutics's fiscal year ends in December.
Where is Hoth Therapeutics based?
Hoth Therapeutics's address is: 1 Rockefeller Plaza, New York, NY, United States, 10020
What is Hoth Therapeutics's ISIN number?
Hoth Therapeutics's international securities identification number is: US44148G1058
What is Hoth Therapeutics's CUSIP number?
Hoth Therapeutics's Committee on Uniform Securities Identification Procedures number is: 44148G105

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site